1. A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled Trial. (27th February 2019) Authors: Perumal, Rubeshan; Padayatchi, Nesri; Yende-Zuma, Nonhlanhla; Naidoo, Anushka; Govender, Dhineshree; Naidoo, Kogieleum Journal: Clinical infectious diseases Issue: Volume 70:Number 1(2020) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Review of Moxifloxacin for the Treatment of Drug‐Susceptible Tuberculosis. (24th July 2017) Authors: Naidoo, Anushka; Naidoo, Kogieleum; McIlleron, Helen; Essack, Sabiha; Padayatchi, Nesri Journal: Journal of clinical pharmacology Issue: Volume 57:Number 11(2017) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antimicrobial stewardship in South Africa: a scoping review of the published literature. Issue 3 (28th November 2019) Authors: Chetty, Sarentha; Reddy, Millidhashni; Ramsamy, Yogandree; Naidoo, Anushka; Essack, Sabiha Journal: JAC-antimicrobial resistance Issue: Volume 1:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes to Antiretroviral Drug Regimens during Integrated TB–HIV Treatment: Results of the Sapit Trial. Issue 2 (February 2014) Authors: Naidoo, Anushka; Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Gengiah, Tanuja N; Padayatchi, Nesri; Gray, Andrew L; Bamber, Sheila; Nair, Gonasagrie; Karim, Salim S Abdool Journal: Antiviral therapy Issue: Volume 19:Issue 2(2014) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis. (January 2018) Authors: Naidoo, Anushka; Ramsuran, Veron; Chirehwa, Maxwell; Denti, Paolo; McIlleron, Helen; Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Singh, Ravesh; Ngcapu, Sinaye; Chaudhry, Mamoonah; Pepper, Michael S; Padayatchi, Nesri Journal: Pharmacogenomics Issue: Volume 19:Number 1(2018) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB. (8th February 2017) Authors: Naidoo, Anushka; Chirehwa, Maxwell; McIlleron, Helen; Naidoo, Kogieleum; Essack, Sabiha; Yende-Zuma, Nonhlanhla; Kimba-Phongi, Eddy; Adamson, John; Govender, Katya; Padayatchi, Nesri; Denti, Paolo Journal: Journal of antimicrobial chemotherapy Issue: Volume 72:Number 5(2017:May) Page Start: 1441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis. (15th February 2019) Authors: Naidoo, Anushka; Chirehwa, Maxwell; Ramsuran, Veron; McIlleron, Helen; Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Singh, Ravesh; Ncgapu, Sinaye; Adamson, John; Govender, Katya; Denti, Paolo; Padayatchi, Nesri Journal: Pharmacogenomics Issue: Volume 20:Number 4(2019) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and Safety of Tenofovir-Containing Antiretroviral Therapy in Women who Acquired HIV while Enrolled in Tenofovir Gel Prophylaxis Trials. Issue 4 (May 2017) Authors: Naicker, Nivashnee; Naidoo, Anushka; Werner, Lise; Garrett, Nigel; Majola, Nelisile; Asari, Villeshni; Baxter, Cheryl; Grobler, Anneke; Karim, Quarraisha Abdool; Karim, Salim S Abdool Journal: Antiviral therapy Issue: Volume 22:Issue 4(2017) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial. Issue 11 (10th November 2022) Authors: Naidoo, Anushka; Dooley, Kelly E; Naidoo, Kogieleum; Padayatchi, Nesri; Yende-Zuma, Nonhlanhla; Perumal, Rubeshan; Dorse, Gillian; Boodhram, Resha; Osuala, Emmanuella Chinonso Journal: BMJ open Issue: Volume 12:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis. (January 2023) Authors: Perumal, Rubeshan; Naidoo, Kogieleum; Naidoo, Anushka; Letsoalo, Marothi P.; Esmail, Aliasgar; Joubert, Ivan; Denti, Paolo; Wiesner, Lubbe; Padayatchi, Nesri; Maartens, Gary; Dheda, Keertan Journal: International journal of infectious diseases Issue: Volume 126(2023) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗